Description
Co-Investigator for the following clinical trials 1. Case 1Y05: Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors (PI, Jennifer Eads) 2. Case 2Y10: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies (PI, Paolo Caimi) 3. Case 2411: Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma (PI, Elma Baron) 4. Case 5913: Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (PI, Basem William) Development and validation of LC-MS/MS methods in collaborations with investigators at CWRU and CCF 1. Simultaneous determination of trimethylamine N-oxide (TMAO), L-carnitine and choline in human plasma (Li Li, CWRU) 2. Simultaneous Determination of dihydrotestosterone and its metabolites in mouse tissue and serum (Monica Montano, CWRU) 3. ATP/ADP, NAD/NADH, NADP/NADPH, ATP/dATP (John Wang, CWRU; Junran Zhang, CWRU) 4. Simultaneous determination of 25-hydroxyvitamin D3, curcumin and its metabolites in human plasma (Basem William, CWRU) 5. Simultaneous determination of decitabine, 5mdC and dNs from human DNA after administration of decitabine (Yogen Saunthararajah, CCF)| Period | 2013 → 2014 |
|---|---|
| Held at | Case Comprehensive Cancer Center, CWRU |